![What is Otrexup Used for & How to Inject It | Otrexup® (methotrexate) injection for subcutaneous use What is Otrexup Used for & How to Inject It | Otrexup® (methotrexate) injection for subcutaneous use](https://otrexup.com/static/media/step%203.1850f0e3c2787f426171.png)
What is Otrexup Used for & How to Inject It | Otrexup® (methotrexate) injection for subcutaneous use
![Otrexup™ Antineoplastic Agent Methotrexate, Preservative Free 15 mg / 0.4 mL Subcutaneous Injection Auto-Injector Pen 4 Devices - Suprememed Otrexup™ Antineoplastic Agent Methotrexate, Preservative Free 15 mg / 0.4 mL Subcutaneous Injection Auto-Injector Pen 4 Devices - Suprememed](https://www.suprememed.com/wp-content/uploads/2022/02/54436001504.jpg)
Otrexup™ Antineoplastic Agent Methotrexate, Preservative Free 15 mg / 0.4 mL Subcutaneous Injection Auto-Injector Pen 4 Devices - Suprememed
![Self-injecting low dose methotrexate for the treatment of arthritis | Rheumatoid Arthritis (RA) support program - homepage | Arthritis Australia Self-injecting low dose methotrexate for the treatment of arthritis | Rheumatoid Arthritis (RA) support program - homepage | Arthritis Australia](http://arthritisaustralia.com.au/wordpress/wp-content/uploads/2017/08/Self-Injecting-image-3-300x259.png)
Self-injecting low dose methotrexate for the treatment of arthritis | Rheumatoid Arthritis (RA) support program - homepage | Arthritis Australia
![What is Otrexup Used for & How to Inject It | Otrexup® (methotrexate) injection for subcutaneous use What is Otrexup Used for & How to Inject It | Otrexup® (methotrexate) injection for subcutaneous use](https://otrexup.com/static/media/otrexup-params@2x.1ae3b6ab237c65f51623.png)
What is Otrexup Used for & How to Inject It | Otrexup® (methotrexate) injection for subcutaneous use
![Evaluation of Usability and Acceptance of a New Autoinjector Intended for Methotrexate Subcutaneous Self-Administration in the Management of Rheumatoid Arthritis | SpringerLink Evaluation of Usability and Acceptance of a New Autoinjector Intended for Methotrexate Subcutaneous Self-Administration in the Management of Rheumatoid Arthritis | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40744-017-0057-3/MediaObjects/40744_2017_57_Fig1_HTML.gif)
Evaluation of Usability and Acceptance of a New Autoinjector Intended for Methotrexate Subcutaneous Self-Administration in the Management of Rheumatoid Arthritis | SpringerLink
![UK High Court finds patent for Metoject® technology invalid on the ground of obviousness - AA Thornton UK High Court finds patent for Metoject® technology invalid on the ground of obviousness - AA Thornton](https://www.aathornton.com/wp-content/uploads/2016/04/iStock_000072544403_Medium.jpg)